Key result
Norepinephrine manipulation fails to modulate task-switching performance across multiple experimental approaches.
Why the study?
The role of norepinephrine neuromodulation in task switching, a form of cognitive flexibility, is poorly understood.
Does norepinephrine manipulation via stress, transcutaneous vagus nerve stimulation, or atomoxetine improve task-switching performance in humans?
RCT (n=120)
Double-blind
Does norepinephrine manipulation via stress, transcutaneous vagus nerve stimulation, or atomoxetine improve task-switching performance in humans?
Norepinephrine manipulation via stress, vagus nerve stimulation, or atomoxetine does not affect cognitive flexibility as measured by task-switching performance.
Norepinephrine manipulations do not enhance task-switching; challenges hypothesized NE role in cognitive flexibility and redirects research to other mechanisms.
Cognitive flexibility allows us to adaptively switch between different responsibilities in important domains of our daily life. Previous work has elucidated the neurochemical basis underlying the ability to switch responses to a previously nonreinforced exemplar and to switch between attentional sets. However, the role of neuromodulators in task switching, the ability to rapidly switch between two or more cognitive tasks afforded by the same stimuli, is still poorly understood. We attempted to fill this gap by manipulating norepinephrine levels using stress manipulation (Study 1a, n = 48; between-group design), transcutaneous vagus nerve stimulation at two different intensities (Study 1b, n = 48; sham-controlled between-group design), and pharmacological manipulation (Study 2, n = 24; double-blind crossover design), all of which increased salivary cortisol measures. Participants repeatedly switched between two cognitive tasks (classifying a digit as high/low [Task 1] or as odd/even [Task 2]), depending on the preceding cue. On each trial, a cue indicated the task to be performed. The cue–stimulus interval was varied to manipulate the time to prepare for the switch. Participants showed typical switch costs, which decreased with the time available for preparation. None of the manipulations modulated the size of the switch costs or the preparation effect, as supported by frequentist and Bayesian model comparisons. Task-switching performance reflects a complex mix of cognitive control and bottom–up dynamics of task-set representations. Our findings suggest that norepinephrine does not affect either of these aspects of cognitive flexibility.
No takes yet. Share an insight, caveat, or question.
Tona et al. (2020) reported an RCT. Stress manipulation, transcutaneous vagus nerve stimulation, and atomoxetine vs. Sham control was evaluated on Size of switch costs and preparation effect. Manipulating norepinephrine levels via stress, transcutaneous vagus nerve stimulation, or atomoxetine did not modulate switch costs or preparation effects in task-switching.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: